coronavirus
cov
caus
human
diseas
symptom
rang
mild
respiratori
symptom
sever
pneumonia
septemb
novel
cov
term
middl
east
respiratori
syndrom
mer
cov
emerg
arabian
peninsula
laboratoryconfirm
case
includ
death
far
world
health
organ
decemb
http
due
distribut
sever
countri
arabian
peninsula
risk
global
spread
travel
pilgrimag
pose
potenti
threat
global
public
health
clinic
pictur
merscov
infect
character
acut
atyp
pneumonia
respiratori
failur
resembl
symptom
caus
sarscov
acut
renal
failur
arf
describ
number
mer
case
potenti
influenc
diseas
sever
arf
neither
typic
featur
sar
commonli
observ
infect
caus
cov
includ
human
note
major
merscov
patient
reportr
underli
medic
condit
diabet
chronic
cardiac
diseas
chronic
renal
diseas
shown
recent
merscov
enter
target
cell
via
sarscov
receptor
via
bind
dipeptidylpeptidas
express
sever
human
tissu
includ
kidney
howev
kidney
infect
compar
merscov
sarscov
postmortem
investig
patient
succumb
merscov
done
assess
potenti
role
kidney
affect
merscov
infect
review
peerreview
commun
report
mer
case
inform
kidney
involv
search
perform
pubm
promedmail
http
wwwpromedmailorg
use
search
term
coronaviru
item
publish
septemb
septemb
broad
search
term
chosen
due
inconsist
nomenclatur
consensu
name
merscov
announc
total
search
reveal
public
includ
articl
pubm
report
prome
figur
identifi
public
review
order
identifi
clinic
descript
merscov
infect
includ
inform
kidney
function
irrespect
whether
point
normal
impair
function
case
two
report
patient
avail
report
detail
clinic
descript
select
identifi
report
extract
inform
patient
sex
age
countri
patient
origin
travel
rout
onset
ill
presenc
absenc
arf
date
onset
arf
day
ill
arf
occur
well
clinic
outcom
death
surviv
among
public
describ
total
merscov
patient
doublereport
patient
could
exclud
total
public
identifi
specif
address
kidney
function
public
total
mer
patient
describ
diseas
onset
date
rang
april
march
tabl
patient
male
mean
age
year
rang
year
origin
jordan
saudi
arabia
qatar
includ
import
case
unit
kingdom
uk
germani
franc
nine
patient
develop
arf
acut
cours
merscov
infect
patient
date
onset
arf
avail
suggest
median
time
day
sd
day
first
symptom
onset
arf
six
patient
arf
fatal
outcom
one
three
patient
without
arf
die
howev
differ
found
fatal
rate
case
without
arf
merscov
infect
statist
signific
investig
laboratori
surrog
suscept
kidney
merscov
comparison
sarscov
analyz
cryoslid
healthi
human
kidney
express
immunofluoresc
stain
use
polyclon
goatantihuman
immunoglobulin
r
system
polyclon
goatantihuman
immunoglobulin
r
system
show
receptor
abundantli
express
healthi
human
kidney
receptor
predominantli
found
epitheli
layer
renal
duct
figur
well
human
primari
epitheli
cell
deriv
duct
epitheli
cell
human
airway
tract
figur
test
whether
kidney
epitheli
cell
actual
infect
invitro
perform
compar
infect
experi
mer
sarscov
use
defin
cultur
primari
kidney
epitheli
cell
hrepc
promocel
heidelberg
bronchoalveolar
epithelium
lung
constitut
primari
target
compart
virus
infect
human
primari
bronchial
epitheli
cell
hbepc
promocel
heidelberg
studi
parallel
summar
figur
primari
cell
passag
seed
densiti
inocul
either
merscov
strain
sarscov
strain
multipl
infect
moi
hour
cell
wash
twice
supernat
harvest
immedi
wash
well
hour
later
cell
check
regularli
appear
cytopath
effect
cpe
light
microscopi
replic
virus
quantifi
titrat
supernat
duplic
plaqu
assay
vero
cell
describ
previous
well
realtim
rtpcr
pronounc
cpe
consist
visibl
strong
cell
lysi
occur
hrepc
upon
infect
merscov
figur
neither
hbepc
upon
merscov
infect
hbepc
hrepc
upon
sarscov
infect
cpe
observ
viru
replic
nevertheless
detect
real
time
rtpcr
experi
confirm
success
infect
figur
cpe
hrepc
consist
round
detach
cell
lead
cell
death
major
cell
alreadi
hour
compar
quantif
infecti
viru
product
sar
merscov
show
merscov
replic
high
titer
hrepc
almost
higher
concentr
infecti
merscov
progeni
hbepc
sarscov
infect
small
differ
primari
kidney
bronchial
epitheli
cell
seen
figur
result
invitro
infect
experi
suggest
differ
kidney
cell
involv
might
exist
sar
merscov
infect
retrospect
analysi
sar
case
patient
acut
renal
impair
diagnos
arf
occur
rather
late
cours
diseas
median
day
appear
first
symptom
literatur
review
mer
case
arf
occur
much
earlier
name
sufficientlydescrib
patient
median
day
date
difficult
compar
clinic
data
experi
anim
model
anim
exhibit
clinic
sign
similar
human
merscov
infect
rhesu
macaqu
none
avail
studi
report
kidney
failur
macaqu
small
amount
viral
rna
detect
kidney
tissu
none
urin
macaqu
might
limit
valu
studi
merscovspecif
kidney
patholog
seen
human
autopsi
data
becom
avail
patient
infect
merscov
postmortem
studi
done
systemat
sar
victim
histopatholog
find
reveal
mainli
acut
tubular
necrosi
without
evid
glomerular
patholog
consid
consequ
system
inflammatori
respons
context
multiorgan
failur
rather
specif
effect
viral
infect
kidney
sarscov
never
success
isol
post
mortem
kidney
tissu
infect
patient
invitro
studi
sarscov
immort
human
proxim
tubular
epitheli
cell
show
replic
without
cell
impair
seen
studi
infect
podocyt
cell
line
lowlevel
replic
glomerular
mesangi
cell
mc
seen
provid
evid
specif
involv
renal
tract
sarscov
infect
contrast
merscov
shown
effici
replic
broad
rang
bat
primat
also
human
kidney
epitheli
cell
line
commonli
use
laboratori
model
abund
express
virus
entri
receptor
kidney
epithelium
argu
receptordepend
limit
viral
kidney
tropism
specif
interfer
merscov
induct
interferon
respons
provid
one
mani
possibl
explan
increas
capac
merscov
replic
kidney
cell
clear
differ
viral
permiss
primari
kidney
epitheli
cell
suggest
cell
appropri
model
identif
hostspecif
restrict
factor
futur
awar
cell
cultur
resembl
limit
model
viral
infect
reflect
complex
infect
invivo
nevertheless
result
congruenc
clinic
observ
wellinvestig
mer
case
viru
urin
detect
late
day
ill
albeit
low
concentr
viru
detect
urin
blood
could
indic
autonom
viru
replic
kidney
note
use
model
assess
abil
cov
persist
environ
shown
merscov
similar
virus
transmit
via
fecalor
rout
author
suggest
could
hint
oralurin
transmiss
merscov
data
viru
shed
urin
cours
diseas
urgent
need
kidney
inde
constitut
site
primari
viru
replic
shed
viru
urin
might
provid
possibl
sourc
humantohuman
transmiss
especi
healthcar
set
among
close
famili
contact
clinic
guidelin
consid
possibl
mer
patient
may
benefit
earli
induct
renoprotect
treatment
author
declar
compet
interest
ie
mam
design
experi
ie
mam
sk
perform
experi
analysi
ie
cd
wrote
manuscript
ie
dng
cd
contribut
final
version
manuscript
author
read
approv
final
manuscript
